Duarte, CANCT06051409Now EnrollingIRB Ready

Ph+ ALL Clinical Trial in Duarte, CA

Access cutting-edge ph+ all treatment through this clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.

Sponsored by Ascentage Pharma Group Inc.

Quick Self-Assessment

See if you qualify for this Duarte location

Preparing your pre-screening questions…

Expert Care in Duarte

Access ph+ all specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ph+ all treatment provided free

Apply for This Duarte Location

Check if you qualify for this ph+ all clinical trial in Duarte, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Duarte

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Duarte site if eligible
  4. 4Begin participation

About This Ph+ ALL Study in Duarte

A global multicenter, open-label, randomized and registrational Phase 3 study to evaluate efficacy and safety of olverembatinib combined with chemotherapy versus investigator's choice of tyrosine kinase inhibitor (TKI) combined with chemotherapy in subjects with newly-diagnosed Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsor: Ascentage Pharma Group Inc.

Who Can Participate

Inclusion Criteria

Newly diagnosed Philadelphia chromosome-positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Expected survival of at least 3 months
Adequate organ function

Exclusion Criteria

A history of chronic myeloid leukemia (CML)
Clinical manifestations of central nervous system (CNS) leukemia or ALL extramedullary infiltration, except lymphadenopathy or hepatosplenomegaly
Previous or current clinical CNS diseases
Autoimmune diseases that may involve the CNS
Use of therapeutic doses of anticoagulants and/or antiplatelet agents; low doses of anticoagulants or antiplatelet agents are allowed
Use a therapeutic drug that has drug interaction with the investigational drug due to other diseases within 7 days or within 5 half-lives (whichever is shorter) prior to the first receipt of the investigational drug
Uncontrolled heart diseases
Any venous thromboembolism in the 6 months prior to randomization, including but not limited to deep vein thrombosis (DVT) or pulmonary embolism
Use of prohibited drugs
Disease or medical condition that is unstable or may affect its safety or compliance with the study
Use of medications known to cause prolonged QT interval
Active infections requiring systemic treatment
Disease that severely affects the oral administration and absorption of drugs, or an active gastrointestinal ulcer
Contraindications to the use of glucocorticoids
Bleeding disorders unrelated to ALL
Plan to undergo major surgery
Allergy to drug ingredients, excipients, or their analogues in the study
Female subjects who are pregnant or breastfeeding or expect to become pregnant during the study period
Other malignant tumors within 2 years
Any symptom or illness that may interfere with the evaluation of the efficacy and safety of the investigational drug, or any other condition or condition that is not appropriate for participation in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Duarte?

Yes, this clinical trial (NCT06051409) has an active research site in Duarte, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ph+ ALL Treatment Options in Duarte, CA

If you're searching for ph+ all treatment options in Duarte, CA, this clinical trial (NCT06051409) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Duarte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ph+ all specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ph+ all clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Duarte, CA

See all leukemia clinical trials recruiting in Duarte — not just this study.

Browse Leukemia Trials in Duarte →

Browse More Trials by Condition

Leukemia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Duarte?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Duarte, CA